Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Repare Therapeutics Inc. (RPTX) had Income from Continuous Operations of $3.26M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.62M |
|
$3.26M |
|
-- |
|
$11.62M |
|
$10.49M |
|
$1.13M |
|
$2.27M |
|
$3.40M |
|
$3.40M |
|
$3.26M |
|
|
Income from Continuous Operations |
$3.26M |
$3.26M |
|
$3.26M |
|
$1.13M |
|
$0.72M |
|
42.97M |
|
43.05M |
|
$0.08 |
|
$0.08 |
|
| Balance Sheet Financials | |
$124.43M |
|
-- |
|
$2.32M |
|
$126.75M |
|
$11.62M |
|
-- |
|
-- |
|
$11.62M |
|
$115.13M |
|
$115.13M |
|
$115.13M |
|
42.99M |
|
| Cash Flow Statement Financials | |
$-42.82M |
|
$30.74M |
|
$0.11M |
|
$84.72M |
|
$72.83M |
|
$-11.89M |
|
$7.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
9.73% |
|
9.73% |
|
-- |
|
29.29% |
|
28.04% |
|
$-41.82M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
1.40 |
|
64.20 |
|
2.83% |
|
2.83% |
|
2.57% |
|
2.83% |
|
$2.68 |
|
$-0.97 |
|
$-0.99 |
|